Related Experiment Videos
Chlamydial antigen detection in urine samples by immunofluorescence tests
A Stary1, M Genç, C Heller-Vitouch
1Ambulatorium für Pilzinfektionen, Wien, Austria.
Infection
|March 1, 1992
Summary
The direct immunofluorescence test (DIF-test) for chlamydia diagnosis in male urine showed lower sensitivity than urethral samples. While useful when genital sampling is impossible, urine DIF-tests cannot replace conventional methods for symptomatic sexually transmitted disease patients.
Area of Science:
- Medical Diagnostics
- Microbiology
- Public Health
Background:
- Chlamydia trachomatis is a leading cause of sexually transmitted diseases (STDs).
- Accurate and accessible diagnostic methods are crucial for effective STD control.
- Direct immunofluorescence testing (DIF-test) offers a rapid diagnostic approach.
Purpose of the Study:
- To evaluate the diagnostic performance of the DIF-test using urethral samples and first catch urine (FCU) in male STD patients.
- To compare the sensitivity and specificity of urine DIF-test against urethral DIF-test and culture.
Main Methods:
- 153 male patients with suspected STDs were enrolled.
- Urethral swabs and FCU were collected for DIF-test and urethral culture.
- DIF-test results were analyzed based on elementary body (EB) counts.
Main Results:
- Urine DIF-test sensitivity was 75% (vs. culture) and 69.2% (vs. urethral DIF-test).
- Urine DIF-test specificity was high at 98.2% (vs. culture) and 95.6% (vs. urethral DIF-test).
- Lower chlamydial EBs in urine samples contributed to false negatives, especially with low urethral EB counts.
Conclusions:
- Urine DIF-test is less sensitive than urethral DIF-test for diagnosing chlamydial infections in symptomatic males.
- Urine DIF-test may be a valuable adjunct when urethral sampling is not feasible.
- Conventional methods remain superior for diagnosing chlamydia in symptomatic STD patients.